| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/17/2008 | CA2657370A1 Anti-hemorrhage medication pack |
| 01/17/2008 | CA2657310A1 Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions |
| 01/17/2008 | CA2657277A1 Process for preparing particles of proteinaceous material |
| 01/17/2008 | CA2657263A1 Methods for treating and limiting fibrotic disorders and keloids |
| 01/17/2008 | CA2657246A1 Anti-cocaine compositions and treatment |
| 01/17/2008 | CA2656836A1 Interleukin 21 and tyrosine kinase inhibitor combination therapy |
| 01/17/2008 | CA2656487A1 Selective caspase inhibitors |
| 01/17/2008 | CA2655042A1 Compositions and methods for targeting cancer-specific transcription complexes |
| 01/17/2008 | CA2551163A1 Methods for treating inflammatory, autoimmune or bone resorption diseases |
| 01/16/2008 | EP1878796A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878795A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878794A2 Compositions and methods for the treatment of immune related diseases |
| 01/16/2008 | EP1878793A1 Novel protein and preventive/remedy for neurodegenerative disease such as polyglutamine disease using the same |
| 01/16/2008 | EP1878749A2 Individulized anti-cancer antibodies |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878746A2 Human monoclonal antibodies to epidermal growth factor receptor |
| 01/16/2008 | EP1878744A1 Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them |
| 01/16/2008 | EP1878743A2 Urotensin-II agonists and antagonists |
| 01/16/2008 | EP1878741A2 Antagonistic peptides of prostaglandin E2 receptor subtype EP4 |
| 01/16/2008 | EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/16/2008 | EP1878454A1 Antihemorrhagic treatment kit |
| 01/16/2008 | EP1878438A2 Ligand/llytic peptide compositions and methods of use |
| 01/16/2008 | EP1878437A2 Pharmacuetical formulations for sustained drug delivery |
| 01/16/2008 | EP1878436A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 01/16/2008 | EP1878425A1 Transdermal absorption accelerator |
| 01/16/2008 | EP1877439A2 Il-21 variants |
| 01/16/2008 | EP1877437A2 Chimeric proteins with phosphatidylserine binding domains |
| 01/16/2008 | EP1877436A2 Use of mapc or progeny therefrom to populate lymphohematopoietic tissues |
| 01/16/2008 | EP1877435A2 Glucagon-like-peptide-2 (glp-2) analogues |
| 01/16/2008 | EP1877434A2 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides |
| 01/16/2008 | EP1877433A2 Vegf variants |
| 01/16/2008 | EP1877431A1 Antiviral peptide against hepatitis c virus |
| 01/16/2008 | EP1877430A2 Compounds and methods for modulating cadherin-mediated processes |
| 01/16/2008 | EP1877427A1 Novel peptides and methods for the treatment of inflammatory disorders |
| 01/16/2008 | EP1877424A1 Inhibitors of protein kinases and uses thereof |
| 01/16/2008 | EP1877423A2 Htm4 used for cell-cycle regulation through its interaction with kap |
| 01/16/2008 | EP1877081A2 Use of tfpi to treat severe bacterial infections |
| 01/16/2008 | EP1877080A1 Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria |
| 01/16/2008 | EP1877078A2 Tropoelastin for promoting endothelial cell adhesion or migration |
| 01/16/2008 | EP1877077A2 An implantable interferon-containing device |
| 01/16/2008 | EP1877076A1 Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration |
| 01/16/2008 | EP1877074A2 Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells |
| 01/16/2008 | EP1877072A2 Bone cement compositions and the like comprising an rnaiii-inhibiting peptide |
| 01/16/2008 | EP1877051A1 MATRIX METALLOPROTEINASE INHIBITORS OF TGFß -INDUCED SUBCAPSULAR CATARACT FORMATION |
| 01/16/2008 | EP1877049A2 Inclusion compounds of dioclein, floranol or analogs with cyclodextrin and their use for treating cardiovascular diseases |
| 01/16/2008 | EP1877038A2 Cell-surface decoration with active agents |
| 01/16/2008 | EP1877037A2 A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 01/16/2008 | EP1789019B1 Powders containing novel oligosaccharide mixtures and methods for producing the same |
| 01/16/2008 | EP1713501B1 Treatment of neurodegenerative diseases by the use of gpr49 |
| 01/16/2008 | EP1601691B1 Shrew paralytic peptide for use in neuromuscular therapy |
| 01/16/2008 | EP1594529A4 Analogues of glp-1 |
| 01/16/2008 | EP1483561B1 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 01/16/2008 | EP1279039B1 Diagnostic assay involving macrophage inhibitory cytokine -1 (mic-1) |
| 01/16/2008 | EP1268835B1 Retinoic acid receptor beta-2 and gene therapy vectors for the treatment of neurological disorders |
| 01/16/2008 | EP1223981B1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 01/16/2008 | EP1210410B1 Metal binding compounds and their use in cell culture medium compositions |
| 01/16/2008 | EP1200118B1 A pharmaceutical formulation comprising megalatran and its prodrug |
| 01/16/2008 | EP1198255B1 Identification of compounds that modify transcriptional responses to hypoxia |
| 01/16/2008 | EP1173480B1 Stereoselective antifibrillogenic peptides |
| 01/16/2008 | EP1107969B1 Collections of compounds |
| 01/16/2008 | EP1100534B1 Equine system for non-surgical artificial insemination |
| 01/16/2008 | EP1091753B1 Antiproliferative and antiviral proteins and peptides |
| 01/16/2008 | EP1074268B1 Preventives or remedies for inflammatory intestinal diseases containing il-6 receptor antagonist antibodies |
| 01/16/2008 | EP1032587B1 Novel exendin agonist compounds |
| 01/16/2008 | EP1019073B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 01/16/2008 | EP0898577B1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE |
| 01/16/2008 | EP0837927B1 Anti-cd80 antibodies |
| 01/16/2008 | EP0795014B1 Costimulatory T cell surface antigen SLAM |
| 01/16/2008 | CN101107361A Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 01/16/2008 | CN101107266A Peptides with neuropeptide-2 receptor (Y2R) agonist activity |
| 01/16/2008 | CN101107265A Cyclic nonapeptide amides |
| 01/16/2008 | CN101107013A Bioactive compositions |
| 01/16/2008 | CN101107007A GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 01/16/2008 | CN101107006A Methods for treating adhesive capsulitis |
| 01/16/2008 | CN101107005A CRIg polypeptide for prevention and treatment of complement-associated disorders |
| 01/16/2008 | CN101107004A Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus |
| 01/16/2008 | CN101106979A Therapeutic peptide formulations for coating microneedles with improved stability containing at least one counterion |
| 01/16/2008 | CN101106978A Controlled release of biological entities |
| 01/16/2008 | CN101106914A Novel nutraceutical compositions |
| 01/16/2008 | CN101104856A Series of non-viral vectors and pharmaceutical composition containing the same |
| 01/16/2008 | CN101104847A Vipera berus snake poison blood coagulation X factor activating enzyme and its extracting method and application |
| 01/16/2008 | CN101104637A Cecropin and its generation bacterial strain and use |
| 01/16/2008 | CN101104078A Polypeptide and protein medicine polyethylene coupling compound |
| 01/16/2008 | CN101104077A Recombinant human interleukin-2 and polyethylene coupling compound |
| 01/16/2008 | CN101104002A Application of fly maggot protein powder in preparing anti-fatigue and immunity-improving product |
| 01/16/2008 | CN101104000A Polypeptide protein active material in scapharca broughtonii and preparation method and application thereof |
| 01/16/2008 | CN101103999A Bone peptide injection preparation technology |
| 01/16/2008 | CN101103984A Pharmaceutical compositions |
| 01/16/2008 | CN100362091C A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug |
| 01/16/2008 | CN100362019C Recombinant erythropoietin with intracorporeal physical activity and modified by macrogol |
| 01/16/2008 | CN100362017C Novel antimicrobial peptides with heparin binding activity |
| 01/16/2008 | CN100362016C Vegetable protein as well as preparation method and application |
| 01/16/2008 | CN100361710C Construction and application of oncolytic adenovirus recombinant of tumor cell specifically expressing immunoregulation factor GM-CSF |
| 01/16/2008 | CN100361706C Expanding diuretic for treating pulmonary edema in perioperative period of hepatic and biliary diseases |
| 01/15/2008 | US7319170 Hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes; N-[(cyclohexylamino)carbonyl]-4-{3-[4-(4-fluorophenoxy)-2-propylphenoxy]propoxy}benzenesulfonamide |
| 01/15/2008 | US7319145 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 01/15/2008 | US7319143 Genetically-engineered MHC molecules |
| 01/15/2008 | US7319141 Stem cell growth factor-like polypeptides |
| 01/15/2008 | US7319140 Binding compounds to DAP12 proteins |
| 01/15/2008 | US7319138 Comprises transcription factor referred to as dragon protein (DRG) for treating and diagnosing nervous system, skin, muscle, bone and eye disorders |